1. Home
  2. CALC vs MSAI Comparison

CALC vs MSAI Comparison

Compare CALC & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • MSAI
  • Stock Information
  • Founded
  • CALC 2011
  • MSAI 1995
  • Country
  • CALC United States
  • MSAI United States
  • Employees
  • CALC N/A
  • MSAI N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • MSAI
  • Sector
  • CALC Health Care
  • MSAI
  • Exchange
  • CALC Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • CALC 26.7M
  • MSAI 26.7M
  • IPO Year
  • CALC N/A
  • MSAI N/A
  • Fundamental
  • Price
  • CALC $1.74
  • MSAI $0.76
  • Analyst Decision
  • CALC Strong Buy
  • MSAI Strong Buy
  • Analyst Count
  • CALC 3
  • MSAI 1
  • Target Price
  • CALC $16.33
  • MSAI $2.50
  • AVG Volume (30 Days)
  • CALC 22.8K
  • MSAI 77.2K
  • Earning Date
  • CALC 05-14-2025
  • MSAI 05-13-2025
  • Dividend Yield
  • CALC N/A
  • MSAI N/A
  • EPS Growth
  • CALC N/A
  • MSAI N/A
  • EPS
  • CALC N/A
  • MSAI N/A
  • Revenue
  • CALC N/A
  • MSAI $6,297,000.00
  • Revenue This Year
  • CALC N/A
  • MSAI $64.25
  • Revenue Next Year
  • CALC N/A
  • MSAI $83.90
  • P/E Ratio
  • CALC N/A
  • MSAI N/A
  • Revenue Growth
  • CALC N/A
  • MSAI N/A
  • 52 Week Low
  • CALC $1.43
  • MSAI $0.70
  • 52 Week High
  • CALC $5.97
  • MSAI $3.33
  • Technical
  • Relative Strength Index (RSI)
  • CALC 47.92
  • MSAI 41.86
  • Support Level
  • CALC $1.61
  • MSAI $0.72
  • Resistance Level
  • CALC $1.73
  • MSAI $0.84
  • Average True Range (ATR)
  • CALC 0.10
  • MSAI 0.06
  • MACD
  • CALC -0.01
  • MSAI -0.00
  • Stochastic Oscillator
  • CALC 33.33
  • MSAI 23.44

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

Share on Social Networks: